NYMI Associates is pleased to offer your patients 3-D TOMOSYNTHESIS MAMMOGRAPHY.
Low dose GeniusTM 3D MAMMOGRAPHY exams are clinically proven to be superior to conventional 2D exams
3-D Tomosynthesis Mammography is a new FDA-approved mammography technology that produces a series of 1mm thick, 3-dimensional digital images of the breast. Breast abnormalities such as masses, distortions, and asymmetric densities are better visualized with 3-D mammography. As reported in JAMA (6/25/2014), the addition of tomosynthesis to digital mammography is associated with a statistically significant increase in cancer detection rate and a decrease in recall rate. Michelle Morgan MD
3-D tomosynthesis is different from a standard mammogram in the same way a CT scan of the chest is different from a standard chest X-ray. Standard mammography includes two X-rays of each breast from different angles, typically top to bottom and side to side. Standard mammograms are very effective, but are limited by dense breasts and overlapping tissue. Digital tomosynthesis overcomes these issues by taking multiple images of each breast allowing visualization of the breast tissue through multiple layers and angles.
The benefits of 3-D tomo include:
- Statistically significant increase in detection of invasive cancers compared to 2D alone.
- Statistically significant decrease in recall rate from screening mammography.
- Statistically significant relative increase in PPV for biopsy.
- Statistically significant relative increase in PPV for recall.
Medicare covers 3D tomosynthesis. But, at this time, not all private insurers are covering this examination. For patients who do not have coverage for this procedure, there is a charge of $100.
As an American College of Radiology designated Breast Center of Excellence, we thank you for trusting us with the care of your patients and look forward to offering them this significant advance in breast cancer screening.
To schedule your patients or for additional information about 3-D TOMOSYNTHESIS MAMMOGRAPHY, please call us at (212) 535-9770.
New York Medical Imaging Associates
Patients at high risk for lung cancer should have regular screening with low-dose CT scans, according to guidelines issued by a consortium of the nation’s… Read More »Make CT Scans Part of Lung Cancer Screening
New York, NY (July 11, 2014) — [New York Medical Imaging Associates] has been designated a Lung Cancer Screening Center by the American College of… Read More »Earns ACR Lung Cancer Screening Center Designation
The American Cancer Society, American College of Radiology, Society of Breast Imaging and American College of Obstetricians and Gynecologists, among others, recommend that all women… Read More »Breast Density – Breast Cancer Screening!
We are proud to announce the launch of our new website.
Maggie Fox NBC News – July 30, 2013 Up to 9 million people who have smoked the equivalent of a pack a day for 30 years might… Read More »9 million smokers should get yearly lung screening, task force says
Screening for lung cancer with low-dose computed tomography (CT) was the most beneficial in people who had the highest likelihood of dying from the disease,… Read More »Low-Dose CT Lung Cancer Screening Best for Highest Risk Patients
WASHINGTON — Annual CT scans of current and former heavy smokers reduced their risk of death from lung cancer by 20 percent, a huge government-financed study has… Read More »November 16, 2010 – CT Scans Cut Lung Cancer Deaths, Study Finds